SCHEMBL6890843

SCHEMBL6890843

Nc1cc(-c2ncc(O)c(=O)[nH]2)ccc1F

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
COMT P21964 2/20 0.56
HSD17B10 Q99714 2/20 0.39
LMNA P02545 1/20 0.39
MAPT P10636 1/20 0.39
CYP2C9 P11712 1/20 0.39
CYP2C19 P33261 1/20 0.39
ESR2 Q92731 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
MAP4K4 O95819 1/20 0.38
NPC1 O15118 1/20 0.37
TP53 P04637 1/20 0.37
PKM P14618 1/20 0.37
RAB9A P51151 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
DAO P14920 5/20 0.37
DDO Q99489 1/20 0.37
CYP1A1 P04798 1/20 0.37
ERCC1 P07992 1/20 0.36
ERCC4 Q92889 1/20 0.36
GUSB P08236 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2436094 0.80 COMT (0.52) COMT
SCHEMBL15577463 0.79 COMT (0.69) COMTCYP2C19DAODDOERCC1
SCHEMBL8383701 0.75 COMT (0.65) COMTDAOGUSB
SCHEMBL6889931 0.75 COMT (0.56) COMTMAPTPKMDAOHRH1
SCHEMBL13810915 0.74 DGAT1 (0.45) HSD17B10LMNAMAPTCYP2C9CYP2C19
SCHEMBL2433653 0.72 COMT (1.00) COMTDAO
SCHEMBL6886838 0.72 COMT (0.68) COMTNPC1RAB9ADAOERCC1
SCHEMBL8384768 0.69 COMT (0.60) COMTMAPTNPC1RAB9AGUSB
SCHEMBL15577542 0.69 COMT (0.60) COMTDAO
SCHEMBL15578915 0.68 COMT (0.58) COMTDAOGUSB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2542084-B1 INHIBITORS OF CATECHOL O-METHYL TRANSFERASE AND THEIR USE IN THE TREATMENT OF PSYCHOTIC DISORDERS MERCK SHARP & DOHME (US) 2017-12-20 EP disclosed
WO-2011109267-A1 INHIBITORS OF CATECHOL O-METHYL TRANSFERASE AND THEIR USE IN THE TREATMENT OF PSYCHOTIC DISORDERS MERCK SHARP & DOHME CORP. (US) 2011-09-09 WO disclosed